Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...
An FDA-approved drug used to treat multiple myeloma and lymphoma also shrank tumors in non-small cell lung cancer (NSCLC) ...
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...
Foundation grants $3.55 million in new research awards, bringing annual total funding awarded to $3.87 million ...
A new molecular imaging agent can accurately identify a crucial biomarker found among many different types of cancer. Precise ...
News Medical on MSN5d
Multi-omic profiling sheds light on chemo-immunotherapy resistance in lung cancerThe study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and ...
Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...
The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), as a single agent, for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has ...
Fibroblastic reticular cells (FRCs) create T-cell-supportive niches within lung cancer tumors, facilitating T-cell migration, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback